Antibody-Based Delivery of IL2 and Cytotoxics Eradicates Tumors in Immunocompetent Mice

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-14-0105
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

CD1d-Based Combination Therapy Eradicates Established Tumors in Mice

Journal of Immunology
AllergyImmunology
2009English

Combined Natural Killer T-Cell Based Immunotherapy Eradicates Established Tumors in Mice

Cancer Research
Cancer ResearchOncology
2007English

LGR5-Targeted Antibody-Drug Conjugate Eradicates Gastrointestinal Tumors and Prevents Recurrence

Molecular Cancer Therapeutics
Cancer ResearchOncology
2016English

Nanobody-Based CAR T Cells That Target the Tumor Microenvironment Inhibit the Growth of Solid Tumors in Immunocompetent Mice

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2019English

Anti-Tumor Activity of an Anti-Endoglin Monoclonal Antibody Is Enhanced in Immunocompetent Mice

International Journal of Cancer
Cancer ResearchOncology
2008English

Alox5 Blockade Eradicates JAK2V617F -Induced Polycythemia Vera in Mice

Cancer Research
Cancer ResearchOncology
2016English

Targeted PDT Agent Eradicates TrkC Expressing Tumors via Photodynamic Therapy (PDT)

Molecular Pharmaceutics
Drug DiscoveryMolecular MedicinePharmaceutical Science
2014English

Photodynamic-Immune Checkpoint Therapy Eradicates Local and Distant Tumors by CD8+ T Cells

Cancer immunology research
Cancer ResearchImmunology
2017English

Injection of Mice With Antibody to Interferon Enhances the Growth of Transplantable Murine Tumors

Journal of Experimental Medicine
MedicineAllergyImmunology
1983English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy